Back

Oncolys BioPharma surges 700 yen as Tokyo biotech stocks attract buying

Verifying
  • Oncolys BioPharma shares surged 700 yen after censavudine trial results appeared in Movement Disorders.
  • Ecomott rose 100 yen after selection for Japan's Go-Tech research and development program.
  • Ex-rights selling pressured retailers, high-yield stocks and other companies across Tokyo on August 28.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.